LAGEVRIO 200 mg/1
molnupiravir · CAPSULE · Merck Sharp & Dohme LLC
No Recall History
Plain English
LAGEVRIO is a capsule containing molnupiravir at 200 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- LAGEVRIO
- Generic Name
- molnupiravir
- NDC Code (Product)
0006-5055- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 200 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Marketing Start
- 12/23/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is LAGEVRIO used for?
LAGEVRIO contains molnupiravir. It is a capsule taken oral. Consult your doctor for specific uses.
Is LAGEVRIO a controlled substance?
LAGEVRIO is not classified as a controlled substance by the DEA.
What is the generic name for LAGEVRIO?
The generic name for LAGEVRIO is molnupiravir. There are no other listed brand versions of molnupiravir.
What is the NDC code for LAGEVRIO 200 mg/1?
The NDC (National Drug Code) for LAGEVRIO 200 mg/1 is 0006-5055, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)